In 2011, Advanced Inhalation Therapies (AIT) was formed and the company developed a proprietary technology to safely deliver Nitric Oxide gas to patients with bronchiolitis and cystic fibrosis.
Advanced Inhalation Therapies Ltd.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”AIT” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://ait-pharm.com
Disease Focus
Development Stage
STOCK CODENASDAQ: AIT
Address2 Derech Meir Weisgal Street, Science ParkRehovotIsrael
2 Derech Meir Weisgal Street, Science Park
Rehovot
Israel
Contact Number+97 2 8 684 3313
+97 2 8 684 3313
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/advanced-inhalation-therapies-ait-ltd” connections=”true” suffix=””]